MondegarAI
CM Management, LLC

Q1 2026 · 13F-HR

CM Management, LLCholdings as filed

Filed 2026-05-08 · accession 0001841857-26-000002

$119.6M
Reported value
71
Positions
2026-03-31
Period end
View analyzed profile →PRO

The Brief · CM Management, LLC · Q1 2026

AI · grounded in 13F

CM Management, LLC closed its position in Taseko Mines Ltd TGB, reducing exposure by $9.62M. The fund also exited positions in Amicus Therapeutics Inc AM6 and Preformed Line Prods Co PLPC, totaling over $10.4M in combined sales. On the buy side, the fund established a new position in Charles Riv Labs Intl Inc CRL for $3.02M and increased its stake in Royalty Pharma PLC SHS RPRX by 66.67%.

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
016230104ALCOALICO INC$8.3M6.90%200,000CommonSOLE
766559702RIGLRIGEL PHARMACEUTICALS INC$6.4M5.31%235,000CommonSOLE
G7709Q104RPRXROYALTY PHARMA PLC SHS$6.0M5.01%125,000CommonSOLE
75025X100RLGTRADIANT LOGISTICS INC$4.6M3.83%650,000CommonSOLE
461147100INTTINTEST CORP$4.5M3.77%330,000CommonSOLE
088929104BGCBGC GROUP INC$4.4M3.68%450,000CommonSOLE
19249H103CHRSCOHERUS BIOSCIENCES INC$3.5M2.97%2,100,000CommonSOLE
159864107CRLCHARLES RIV LABS INTL INC$3.0M2.52%17,500CommonSOLE
567908108HZOMARINEMAX INC$3.0M2.49%110,000CommonSOLE
65158N102NMRKNEWMARK GROUP INC$2.8M2.38%190,000CommonSOLE
700517105PKPARK HOTELS RESORTS INC$2.6M2.20%250,000CommonSOLE
68622V106OGNORGANON & CO COMMON$2.4M2.00%400,000CommonSOLE
92556V106VTRSVIATRIS INC$2.4M1.98%175,000CommonSOLE
760281204RBCAAREPUBLIC BANCORP KY$2.3M1.89%32,000CommonSOLE
041242108ARKOARKO CORP$2.1M1.74%375,000CommonSOLE
28617K101ELDNELEDON PHARMACEUTICALS INC$2.0M1.67%650,000CommonSOLE
G3223R108EGEVEREST RE GROUP LTD$2.0M1.64%6,000CommonSOLE
04683R106AVIRATEA PHARMACEUTICALS INC$1.9M1.60%355,000CommonSOLE
320218100THFFFIRST FINL CORP IND$1.9M1.59%30,000CommonSOLE
11040G103VTOLBRISTOW GROUP INC$1.9M1.57%40,000CommonSOLE
011659109ALKALASKA AIR GROUP INC$1.8M1.54%50,000CommonSOLE
45768S105IOSPINNOSPEC INC$1.8M1.47%24,000CommonSOLE
40434L105HPQHP INC$1.7M1.45%90,000CommonSOLE
P31076105CPACOPA HOLDINGS SA$1.7M1.42%15,000CommonSOLE
30052C107EOLSEVOLUS INC$1.6M1.37%400,000CommonSOLE
462260100IOVAIOVANCE BIOTHERAPEUTICS INC$1.6M1.32%450,000CommonSOLE
69553P100PDPAGERDUTY INC$1.6M1.30%250,000CommonSOLE
22407B108COYACOYA THERAPEUTICS INC COMMON$1.5M1.24%375,000CommonSOLE
040712101ARKRARK RESTAURANTS CORP$1.5M1.23%225,000CommonSOLE
82537J108SISHOULDER INNOVATIONS INC COMMON$1.5M1.21%100,000CommonSOLE
78573M104SABRSABRE CORP$1.4M1.21%999,900CommonSOLE
M25133105CGNTCOGNYTE SOFTWARE LTD ORD$1.4M1.19%175,000CommonSOLE
194014502ENOVENOVIS CORPORATION$1.4M1.14%60,000CommonSOLE
18507C103CLPTCLEARPOINT NEURO INC$1.4M1.14%150,000CommonSOLE
92645B103VCTRVICTORY CAP HLDGS INC COM$1.3M1.09%20,000CommonSOLE
199333105CMCOCOLUMBUS MCKINNON CORP N Y$1.3M1.09%90,000CommonSOLE
98419J206XOMAXOMA CORP DEL$1.3M1.05%40,000CommonSOLE
46333X108IRWDIRONWOOD PHARMACEUTICALS INC COM$1.2M1.03%350,000CommonSOLE
744320102PRUPRUDENTIAL FINL INC$1.2M1.02%12,500CommonSOLE
810186106SMGSCOTTS MIRACLE GRO CO$1.2M1.02%20,000CommonSOLE
02341Q205DITAMCON DISTRG CO$1.2M1.02%13,500CommonSOLE
336901103SRCE1ST SOURCE CORP$1.2M1.01%17,500CommonSOLE
084680107BBTBERKSHIRE HILLS BANCORP INC$1.2M1.00%40,000CommonSOLE
015271109AREALEXANDRIA REAL ESTATE EQ IN$1.2M0.97%25,000CommonSOLE
74319B502PROFPROFOUND MED CORP$1.1M0.95%175,000CommonSOLE
594918104MSFTMICROSOFT CORP$1.1M0.93%3,000CommonSOLE
023135106AMZNAMAZON COM INC$1.0M0.87%5,000CommonSOLE
G4388N106HELEHELEN OF TROY CORP LTD$1.0M0.84%70,000CommonSOLE
880345103TNCTENNANT CO$996,0000.83%15,000CommonSOLE
42704L104HRIHERC HLDGS INC$995,5000.83%10,000CommonSOLE
171484108CHDNCHURCHILL DOWNS INC$898,3000.75%10,000CommonSOLE
23283X206CTSOCYTOSORBENTS CORP$836,1420.70%1,476,500CommonSOLE
298736109EEFTEURONET WORLDWIDE INC$829,6250.69%12,500CommonSOLE
427746102HRTXHERON THERAPEUTICS INC$800,1000.67%1,000,000CommonSOLE
651229106NWLNEWELL BRANDS INC$686,0000.57%200,000CommonSOLE
05366Y201AVNWAVIAT NETWORKS INC$678,3000.57%30,000CommonSOLE
81761L102SVCSERVICE PPTYS TR$677,5000.57%500,000CommonSOLE
04546C304ASRTASSERTIO HOLDINGS INC$667,1000.56%35,000CommonSOLE
35168W103GUTSFRACTYL HEALTH INC$640,9200.54%1,400,000CommonSOLE
36870H103GNLXGENELUX CORPORATION$605,0000.51%250,000CommonSOLE
68764Y207OSTXOS THERAPIES INCORPORATED$564,0000.47%400,000CommonSOLE
854502101SWKSTANLEY BLACK & DECKER INC$532,9500.45%7,500CommonSOLE
49271V100KDPKEURIG DR PEPPER INC$526,6000.44%20,000CommonSOLE
974637100WGOWINNEBAGO INDS INC$464,8500.39%15,000CommonSOLE
13462K109CWHCAMPING WORLD HLDGS INC$409,8000.34%60,000CommonSOLE
29415J205NVNOENVVENO MEDICAL CORPORATION$361,7820.30%35,714CommonSOLE
51654W101LTRNLANTERN PHARMA INC$342,5000.29%250,000CommonSOLE
19243B102CGTXCOGNITION THERAPEUTICS INC$303,8000.25%400,000CommonSOLE
28657F103ELTXELICIO THERAPEUTICS INC$267,2500.22%25,000CommonSOLE
09060U606BCDABIOCARDIA INC$157,3000.13%130,000CommonSOLE
231269309CRISCURIS INC$82,0950.07%150,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.